Type I interferons bind to two cell surface receptors, ifnar1 and ifnar2, as the first step in the activation of several signal transduction pathways that elicit an antiviral state and an anti-proliferative response. Here, we quantitatively mapped the complete binding region of ifnar2 on interferon (IFN)␣2 by 35 individual mutations to alanine and isosteric residues. Of the six "hot-spot" residues identified (Leu-30, Arg-33, Arg-144, Ala-145, Met-148, and Arg-149), four are located on the E-helix, which is located at the center of the binding site flanked by residues on the A-helix and the AB-loop. The contribution of residues of the D-helix, which have been previously implicated in binding, proved to be marginal for the interaction with the extracellular domain of ifnar2. Interestingly, the ifnar2 binding site overlaps the largest continuous hydrophobic patch on IFN␣2. Thus, hydrophobic interactions seem to play a significant role stabilizing this interaction, with the charged residues contributing toward the rapid association of the complex. Relating the anti-viral and anti-proliferative activity of the various interferon mutants with their affinity toward ifnar2 results in linear function over the whole range of affinities investigated, suggesting that ifnar2 binding is the rate-determining step in cellular activation. Dose-time analysis of the anti-viral response revealed that shortening the incubation time of low-level activation cannot be compensated by higher IFN doses. Considering the strict dependence of the cellular response on affinity, these results suggest that for maintaining transcription of IFN-responsive genes over a longer time period, low but continuous signaling through the IFN receptor is essential.
Type I interferons bind to two cell surface receptors, ifnar1 and ifnar2, as the first step in the activation of several signal transduction pathways that elicit an antiviral state and an anti-proliferative response. Here, we quantitatively mapped the complete binding region of ifnar2 on interferon (IFN)␣2 by 35 individual mutations to alanine and isosteric residues. Of the six "hot-spot" residues identified (Leu-30, Arg-33, Arg-144, Ala-145, Met-148, and Arg-149), four are located on the E-helix, which is located at the center of the binding site flanked by residues on the A-helix and the AB-loop. The contribution of residues of the D-helix, which have been previously implicated in binding, proved to be marginal for the interaction with the extracellular domain of ifnar2. Interestingly, the ifnar2 binding site overlaps the largest continuous hydrophobic patch on IFN␣2. Thus, hydrophobic interactions seem to play a significant role stabilizing this interaction, with the charged residues contributing toward the rapid association of the complex. Relating the anti-viral and anti-proliferative activity of the various interferon mutants with their affinity toward ifnar2 results in linear function over the whole range of affinities investigated, suggesting that ifnar2 binding is the rate-determining step in cellular activation. Dose-time analysis of the anti-viral response revealed that shortening the incubation time of low-level activation cannot be compensated by higher IFN doses. Considering the strict dependence of the cellular response on affinity, these results suggest that for maintaining transcription of IFN-responsive genes over a longer time period, low but continuous signaling through the IFN receptor is essential.
Type I interferons (IFN)
1 are a family of homologous cytokines, which potently elicit an anti-viral and anti-proliferative state in cells. All human type I IFNs (IFN␣, ␤, , and ) bind to a cell surface receptor consisting of two transmembrane proteins, ifnar1 (1) and ifnar2 (2) , which associate upon binding. Binding of IFN to its receptor mediates activation of numerous genes (3) through different signal transduction pathways (reviewed in Ref. 4) . Intriguingly, different expression profiles are induced by different IFNs, apparently through the same receptor, with particular differences between IFN␣ and IFN␤ (3, 5) . However, the molecular mechanisms underlying the functional differences between IFNs are still unknown. Type I IFNs belong to the class of helical cytokines (6) and are built by five helices. The structure of several type I IFNs have been resolved, such as murine IFN␤ (7), human IFN␣2 (8, 9) , human IFN␤ (10) , and ovine IFN (11) . Mutational studies have revealed functionally important residues on IFNs (reviewed in Ref. 12) , which can be ascribed to distinct functional epitopes that interact with ifnar1 and ifnar2 (13, 14) . The binding site for ifnar2 was mainly mapped on the AB-loop and D-helix and the binding site for ifnar1 on the C-helix. However, comparison with homologous cytokines suggests the involvement of the E-helix in the binding of ifnar2 (8, 13, 15) .
Understanding the basis of IFN signaling at the molecular level requires establishing in quantitative terms the correlation between IFN cellular activity and its structural, kinetic, and thermodynamic binding parameters for its receptors. Having established methods for expression, refolding, and purification of the extracellular domain of ifnar2 (ifnar2-EC), we have recently analyzed the kinetics and thermodynamics of the interaction between ifnar2-EC and IFN␣2 by solid phase detection (16) . We mapped the binding interface of IFN␣2⅐ifnar2-EC by single alanine mutations and determined the precise energetic contribution of individual residues in the complex (16, 17) . Only very minor contributions of residues on the D-helix were observed, and only three residues on the AB-loop contributed more than 1.0 kcal/mol, suggesting additional elements of IFN␣2 are involved in binding ifnar2. In this study, we present a complete high-resolution map of the binding site of IFN␣2 for ifnar2 in energetic and kinetic terms. Based on a large set of single-residue IFN␣2-mutants covering several orders of magnitude in binding affinity, we have correlated the cellular activity exerted by these IFNs with the structural, thermodynamic, and kinetic parameters of their interaction with ifnar2-EC.
EXPERIMENTAL PROCEDURES
Materials-EDC and NHS were purchased from Fluka. Monoclonal anti-ifnar2-EC 46.10 and 117.7, which bind non-competitively and do not inhibit IFN binding, were a gift from Daniela Novick, (Weizmann Institute of Science). WISH and Daudi cells were a gift from Daniela Novick.
Protein Expression and Purification-IFN␣2 and ifnar2-EC were expressed in Escherichia coli and purified by ion exchange and sizeexclusion chromatography as described earlier (16, 17) . Protein concentrations were determined from the absorbance at 280 nm (16) with ⑀ 280 ϭ 18,070 M Ϫ1 for IFN␣2 and ⑀ 280 ϭ 26,500 M Ϫ1 for ifnar2-EC. Protein purity was analyzed by SDS-polyacrylamide gel electrophoresis under non-reducing conditions, and concentrations were verified by quantitative evaluation of the protein bands compared with wild-type standard. The concentration of active IFN␣2 protein was determined for all mutants by analytical gel filtration with ifnar2-EC as described earlier (16) . Site-directed Mutagenesis-Site-directed mutagenesis was carried out by polymerase chain reaction amplification of the complete plasmids for expression (pT72C␣2) with 18 -21 nucleotide primers containing the mutated codon using high fidelity polymerases pwo (Roche Molecular Biochemicals) and pfu (Stratagene) as previously described in detail (18) . After phosphorylation and ligation, the mutated plasmids were transformed into E. coli TG1 cells. The sequence of the whole expressed gene containing the mutation was verified by DNA sequencing.
Measurements of Kinetics and Affinity-The interaction between recombinant ifnar2-EC and IFN␣2 was monitored by an optical probe called reflectometric interference spectroscopy (RIfS) under flowthrough conditions (19) . This method detects biomolecular interaction at interfaces as a change in the apparent optical thickness of a thin silica layer. The complete experimental setup for this methodology has been previously described in detail (20, 21) . Binding to the surface is monitored as a shift in the interference spectrum. A shift of 1 pm corresponds to approximately 1 pg/mm 2 protein on the surface. All measurements were carried out using HBS (20 mM HEPES, pH 7.5, 150 mM NaCl, and 0.01% Triton X-100) as a running buffer. The nonneutralizing anti-ifnar2-EC mAb 46.10 was covalently coupled to the carboxyl-functionalized dextran layer on the transducer surface by standard BIAcore protocols. Ifnar2-EC (20 g/ml, 800 nM) was captured by the immobilized antibody, followed by cross-linking with a second mAb (117.7) at a concentration of 10 g/ml (65 nM). The binding curves were evaluated with the BIAevaluation software (Biacore AB, Sweden) using simple one-to-one kinetics models. For the determination of dissociation constants K D , the equilibrium response was plotted versus the concentration and fitted by the law of mass action.
Anti-viral Protection Activity Assay-Anti-viral activity of wild-type and mutant IFN␣2 was assayed as the inhibition of the cytopathic effect of vesicular stomatitis virus (VSV) on human WISH cells (22) . The relative activity of IFN␣2-mutants was determined as the concentration needed for 50% protection of the cells relative to the concentration of wild-type IFN␣2 needed for 50% protection. Dose-time experiments were carried out by occluding free interferon after different incubation times. At time 0, IFN␣2 was added at concentrations between 1 and 250 pM to a culture of human WISH cells. At different time points, a quantity of ifnar2-EC was added (1-5 M), which was calculated to reduce the free IFN concentration in the sample to less than 0.5 pM, which was below the threshold for cell protection in our assay. In all cases, the culture was challenged with VSV 4 h after the addition of IFN␣2. After 18 h of growth, the cells were stained with crystal violet to determine the proportion of intact cells.
Anti-proliferative Assay-The anti-proliferative activity of IFN␣2 on Daudi cells was assayed as follows. Two-fold serial dilutions of IFN␣2 (10 -12 samples altogether) were prepared in flat-bottomed 96-well plates, with final concentrations of wild-type IFN␣2 ranging from 0.04 to 82 pM. The concentration range for IFN␣2 mutants was adjusted according to the anticipated anti-proliferative activity for the specific mutant as estimated from its affinity. 100 l of human Daudi Burkitt's lymphoma cells growing in RPMI 1620 supplemented with 10% fetal calf serum and 4 mM L-glutamine were added into each well and were grown for an additional 60 h with IFN. The number of living cells was then determined using a cell staining kit (Biological Industries Co, Israel) based on the colorimetric detection of the cleavage of the tetrazolium salt XTT into formazan. The XTT reaction solution was added according to the manufacturer's recommendation for a period of 5 h, after which the absorbance at 475 nm was recorded in an ELISAreader. The relative anti-proliferative activities of IFN␣2-mutants were determined as the concentration needed for 50% inhibition of cell growth relative to the concentration of wild-type IFN needed for 50% inhibition.
RESULTS
Binding Assays by Label-free Detection-The interaction of IFN␣2 with ifnar2-EC was characterized by a biosensor system based on reflectometric interference spectroscopy (RIfS) using purified proteins for all measurements. In previously published experiments, ifnar2-EC was covalently immobilized via its exposed amino groups by amine-coupling chemistry (17) . From these studies, a dissociation constant of about 10 nM was determined for the wild-type IFN␣2⅐ifnar2-EC complex, with an association rate constant of 2 ϫ 10 6 M Ϫ1 s Ϫ1 and a dissociation rate constant of 0.02 s Ϫ1 . Because we observed heterogeneous affinity of covalently coupled ifnar2-EC, we investigated alternative methods for immobilization including biotinylated ifnar2-EC and capturing with monoclonal antibodies (mAb). An efficient protocol was developed based on affinity capturing and cross-linking with two different monoclonal anti-ifnar2-EC antibodies (46.10 and 117.7) that bind ifnar2-EC non-competitively and do not interfere with interferon binding; ifnar2-EC was captured from the solution by the surface bound mAb 46.10, followed by cross-linking with mAb 117.1, which virtually abolished leak-out because of dissociation. This method of immobilization provided a stable surface, which was readily regenerated by a short pulse of 50 mM HCl. Thus, the immobilized mAb 46.10 could be repeatedly reloaded with fresh ifnar2-EC. In addition to the simple regeneration of this surface, we observed a significant improvement in the homogeneity of the ifnar2-EC binding sites compared with measurements done using the standard amine coupling method. This proved to be particularly advantageous for retrieving direct binding data for some of the weaker binding IFN␣2 mutants (e.g. R33A), which could not be measured using the standard amine-coupling method. A comparison of IFN␣2 binding to ifnar2-EC immobilized to the surface via both methods clearly shows that absolute rates of association and dissociation differ (Fig. 1a) , with the affinity of IFN␣2 toward mAb-immobilized ifnar2-EC being 2.5-fold higher than toward the amine-coupled receptor. The difference in affinity is a result of a faster k a and a slower k d (Fig. 1a) . However, the relative changes of rate constants and affinities upon mutation of IFN␣2 were in good agreement, as demonstrated in Fig. 1b . Thus, the changes in free energy of interaction upon mutation (⌬⌬G 0 ) determined from measurements on both surfaces were consistent.
The time resolution in solid phase detection is typically limited to the subsecond range because of the inertia of flowthrough sample handling. With the biosensor system used in this study, dissociation rate constants of up to ϳ0.3 s Ϫ1 were properly resolved, which is about 30-fold faster than the rate measured for the interaction of the wild-type proteins. The dissociation of several low-affinity IFN␣2 mutants was too fast to be directly determined. In these cases, the affinity was determined from the concentration dependence of the equilibrium binding response on the sensor surface. The binding affinities as calculated from the rate constants corresponded well to those obtained from analysis of the equilibrium response (Fig. 1c) .
Mapping the Binding Site of IFN␣2 for ifnar2-The AB-loop and to a lesser extent the D-helix have been previously identified as being important for IFN activity and ifnar2 binding (12) . However, mapping these residues on the structure of IFN␣2 (17) , as well as homology considerations, raised the possibility that the binding interface extends toward the E-helix. Here, most surface exposed residues of the E-helix were individually mutated to Ala, and their contribution to binding was determined. The mutations R144A, A145G, M148A, and R149A each resulted in a decrease in binding affinity of over 20-fold, corresponding to a loss of more than 2 kcal/mol of binding free energy (Table I and see Fig. 4a ) (the D146A mutant did not refold and thus could not be measured). The mutations S152A and L153A reduced binding by 6-and 13-fold, respectively, whereas mutation N156A had no significant effect on binding (Table I) . Extending the search to the A-helix revealed that Leu-15 was also involved in the interaction with ifnar2, whereas mutating Met-16 had no effect on binding. On the D-helix, only Lys-133 contributed more than 0.5 kcal/mol of binding free energy. Although most of the residues on the AB-loop have been analyzed previously (17) , these results were confirmed here with ifnar2-EC immobilized via mAbs. Furthermore, the K D of mutants with extremely low affinity were quantified appropriately. On the AB-loop, residues Leu-30 and Arg-33 contributed 3.8 and 5.5 kcal/mol binding free energy (relative to Ala). Leu-26, Phe-27, Lys-31, Asp-32, and His-34 contributed between 0.5-2 kcal/mol of binding free energy (Table I), whereas residues Arg-22, Arg-23, Ile-24, Ser-25, Ser-28, Asp-35, and Gln-40 do not contribute significantly to binding. For most of the mutations, the change in binding affinity was dictated by a change in k d , whereas k a was constant. The exceptions were R144A, where k a decreased 10-fold whereas k d increased by 4-fold, and K133A where k a decreased by 5-fold whereas k d increased by less then 2-fold. Thus, in these cases the mutations affected mostly k a (Table I) .
Mapping the change in binding free energy upon mutation on the structure of IFN␣2 gives a consistent picture of the binding site (Fig. 2a) . Six hot-spot residues are located in the center of the binding site, each of them decreasing ⌬⌬G 0 mut-wt by more than 2 kcal/mol (Leu-30, Arg-33, Arg-144, Ala-145, Met-148, and Arg-149, red). Nine additional residues contribute between 0.5-2 kcal/mol (Leu-15, Leu-26, Phe-27, Lys-31, Asp-32, His-34, Lys-133, Ser-152, and Leu-153). Residues that contribute less then 0.5 kcal/mol of free binding energy, and thus are probably not within the binding interface, surround the residues mapped within the binding site. The binding site is composed of residues in the A-and E-helices and the AB-loop, with the hot-spot residues being located at the center of the binding site (Fig. 2b) .
In the published NMR structure of IFN␣2, the C-terminal is not involved in any specific interaction with the rest of the protein and seems to be flexible. To assess the importance of the C-terminal residues to IFN activity, a truncated IFN␣2 protein (missing the five last residues) was produced. Analytical gel filtration in the absence and presence of ifnar2-EC demonstrated that this protein folds correctly and retains ifnar2 binding activity (data not shown). Similar affinity and rate constants were found for the truncated protein compared with the wild-type protein (Table I) . Thus, the C terminus of IFN␣2 does not seem to participate in ifnar2 binding. Previous studies of C-terminal-truncated interferons have given mixed results, from retaining most of the antiviral activity (23) to losing most of it (for fragment 1-158, Ref. 24) .
Isosteric Mutations of Leu-30 and Arg-33-A significant advantage of immobilizing ifnar2-EC by affinity capturing is the low level of nonspecific background, even at very high IFN␣2 concentrations. Consequently, we could directly determine the binding affinities of the IFN␣2 mutations L30A, L30V, R33A, R33K, and R33Q, a task not feasible with ifnar2-EC immobilized by amine-coupling. An Ala at position 30 reduced the binding affinity toward ifnar2-EC to 1.7 M, whereas the R33A mutant had an affinity of 28 M. The cause for the large decrease in affinity of these two mutations was further investigated by isosteric mutations. The binding affinity of L30V is 260 nM (compared with 4 nM of the wild-type), thus most of the binding is lost by shortening the branched side chain by a single methylene unit. For Arg-33, the regain of binding affinity upon introducing isosteric mutations was even smaller; an affinity of 8 M was determined for R33K, whereas R33Q caused a decrease in affinity to 86 M. The small difference in binding affinity between R33A and R33K is surprising, as Lys was often found to replace Arg without much change in binding or activity. Possibly, mutating Arg-33 affects the structural integrity of the binding site.
Anti-viral Activity Versus Affinity of IFNa2 Mutants-Binding of IFN to ifnar2 is the very first step initiating a complex signal transduction cascade that activates the anti-viral state in cells. The interferon concentration which gives 50% protection of human WISH cells challenged with VSV is a good measure for its biological activity. Here, the concentrations giving rise to 50% protection (I 50 mut ) for the various IFN␣2 mutants were determined. The relative anti-viral activity p AV was obtained by normalizing to the concentration measured for wild-type IFN␣2 (I 50 wt ) with p AV ϭ I 50 wt / I 50 mut . Previously, a good correlation between the binding affinity and the anti-viral activity was observed for a set of mutants located in the AB-loop and the D-helix (17) . Here, this correlation is extended to vir- Table I. tually a complete set of residues involved in the interaction of IFN␣2 with ifnar2-EC, covering 4 orders of magnitude of binding affinities. To weigh binding affinities over this whole range equally, we correlated this data on a logarithmic scale. An excellent linear correlation between the affinity of IFN␣2 toward ifnar2-EC and anti-viral activity was observed for all mutants (Fig. 3a) . The slope of this curve is 0.72, which is probably because of the constant contribution of ifnar1 toward formation of the active ternary complex. Notably, the relation between affinity and activity is maintained also for R144A and K133A. In these two cases, the affinity is mainly affected by a large reduction in k a (10-and 5-fold, respectively). Thus, antiviral activity is related to the binding affinity, independent of the relative contributions of k a and k d . Truncating IFN␣2 at residue Ser-160 had no significant effect on the anti-viral activity compared with the wild-type protein, thus confirming that the five C-terminal residues are not essential for IFN function.
Anti-proliferative Activity Versus Affinity of IFN␣2 Mutants-The level of the anti-proliferative response of IFN on Daudi cells is a well established marker that determines the potency of IFNs. Furthermore, it has been suggested that the anti-proliferative response is mediated by different elements of the signal transduction pathways than those mediating antiviral activity (4). Anti-proliferative activity of the various IFN␣2 mutants was determined by measuring the relative number of living cells 60 h after the addition of IFN␣2, using a colorimetric assay (detecting the cleavage of the tetrazolium salt XTT to formazan). For exponentially growing Daudi cells, ϳ0.3 pM wild-type IFN␣2 incubated over 60 h was required to inhibit cell growth by 50% (Fig. 3b) . Plotting the relative antiproliferative potency of the various IFN␣2 mutants versus their relative binding affinity toward ifnar2-EC yielded a linear correlation (Fig. 3c) . The slope of the (logarithmic) affinity-activity plot is 0.84. A detailed graphic comparison of the relative contributions toward binding and activity of the individual residues is presented in Fig. 4 . On the AB-loop, only two residues (Leu-30 and Arg-33) caused a significant decrease in all three parameters. Except for Lys-133, none of the residues located on the D-helix are involved in binding or in biological activity. Many of the residues on the E-helix are important for binding and activation of the biological response. Within the error of the assays, the relative contribution to binding are in agreement with the changes in biological activity.
Time-dose Relationship for Activating the Anti-viral Response-IFN-induced association of ifnar1 and ifnar2 causes phosphorylation and activation of STAT. It has previously been observed that the initiation of the anti-viral state depends on the continuous presence of interferon for at least 4 h prior to viral infection (25) . Here we wanted to determine whether higher concentrations of interferon (which increases the number of activated receptors) would shorten the time needed to activate the anti-viral state. The availability of large amounts of purified ifnar2-EC enabled us to elegantly block receptor stimulation by IFN after specific time periods. Complete protection was achieved at an IFN␣2 concentration of 16 pM after at least a 4-h incubation in the presence of IFN␣2, prior to its occlusion by ifnar2-EC (Fig. 5) . Occluding free IFN␣2 from the medium after less than 4 h did not result in the activation of the anti-viral state. Adding interferon at much higher concentrations (up to 250 pM) did not shorten the time of continuous interferon presence needed to activate the anti-viral state (Fig.  5) . This is despite the larger number of activated receptor complexes per cell expected at higher IFN␣2 concentrations.
DISCUSSION
Structural and functional aspects of IFN signaling through its receptors ifnar1 and ifnar2 are currently understood only on a basic level. IFN-induced association of the receptors stimulates a variety of signaling transduction pathways by activating the associated kinases Jak1 and Tyk2. However, the fact that different IFNs elicit different response profiles through the same receptor requires detailed correlation of structural and functional properties of IFNs. Here we present a virtually complete high-resolution picture of the ifnar2-binding epitope of IFN␣2, obtained by extensive mutational analysis using direct binding assays to evaluate affinity and kinetics of the interaction between IFN␣2 and ifnar2-EC. Based on a large set of IFN␣2 mutants, we investigated in detail the role of kinetics and affinity of the IFN␣2-ifnar2 interaction for IFN signaling and activity. By individually mutating many of the surfaceexposed residues located on helices A, D, and E, as well as on the AB-loop to Ala, we quantitatively mapped their energetic contributions. We located the ifnar2 binding site on the first half of the AB-loop (residues 26 -34), residue 133 on the D-helix, the E-helix (residues 144 -153), and on a small part of the A-helix (L15). Two additional residues that may affect binding are Arg-12 and Glu-146, but the corresponding Ala mutants failed either to express or fold. Mutating Glu-146 to Lys was previously shown to cause a large reduction in biological activity, albeit this was explained as resulting from the role of Glu-146 in stabilizing the AB-loop (26) . In the center of the ifnar2 binding site is the E-helix, flanked by helix A and the AB-loop from both sides. The D-helix faces a different surface of the protein than the suggested binding site, in agreement with its marginal contribution to binding of ifnar2 (Fig. 2b) . Coloring all mutated residues according to their contribution to binding (Fig. 2a) shows that the ifnar2 binding site on IFN␣2 is surrounded by inert residues (blue). Assuming that the interface consists of a continuous surface patch, we conclude that most of the ifnar2 binding site has been identified. The classical interface structure consists of hot-spot residues (⌬⌬G 0 Ͼ 2 kcal/mol) located at the center of the binding site, surrounded by residues, which have a smaller impact on binding (27, 28). On IFN␣2, Ala-145 is located at the center of a pocked, enclosed by Arg-22, Leu-26, Phe-27, Arg-33, Arg-144, Met-148, and Met-149 (Fig. 2a) . All of these residues, except for Arg-22, were found to contribute significantly to binding, including 5 of the 6 hot-spot residues identified (except for Leu-30). Residues Leu-15, Ala-19, Ile-24, Ser-28, Leu-30, Lys-31, His-34, Asp-35, Lys-133, Ser-152, and Leu-153 form the next shell surrounding this core of the binding site. From this group of residues, only Leu-30 contributes more than 2 kcal/mol to binding, whereas Leu-15, Lys-31, His-34, Ser-152, and Leu-153 contribute between 0.5-2 kcal/mol of free energy of binding. Removing the five terminal residues of IFN␣2 (161-165) did not affect binding to ifnar2-EC, nor did it have any effect on the magnitude of biological anti-viral or anti-proliferative activity. As these residues are conserved in most human interferons (but are truncated in IFN␣7), their biological role in a whole organism needs further evaluation.
About half of the 18 residues surrounding Ala-145 are hydrophobic. The hydrophobicity of the ifnar2 binding site relative to the IFN␣2 protein surface was calculated using the computer program QUILT, which calculates hydrophobic patches on protein surfaces (29) . The largest continuous hydrophobic patch on IFN␣2 overlays with the ifnar2 binding site, as determined by mutagenesis (Fig. 6) . Strikingly, performing this calculation on a model of ifnar2 identified the IFN␣2 binding site on ifnar2 also as the largest continuous hydrophobic patch on ifnar2 (Fig. 6) . Although the IFN␣2-ifnar2 binding interface is hydrophobic, electrostatic forces have been shown to play a significant role in steering these two proteins to achieve fast binding (16) . The electrostatic potential on IFN␣2 at the ifnar2 binding site is clearly positive (Fig. 6 ). This positive potential stems from the many Arg and Lys residues located both within and around the binding site (9 versus only 5 AspϩGlu). Interestingly, performing a similar analysis on the IFN␣2 binding site on ifnar2 shows that, although this binding site exerts a strong negative electrostatic potential, most of the negatively charged residues seem to be located either at the periphery or outside the physically interacting surfaces (Fig. 6 and Ref. 17) . From the large complementary hydrophobic binding surfaces between IFN␣2 and ifnar2, it is speculated that hydrophobic interactions are of major importance in stabilizing this complex, whereas charged residues, many of which are located at the periphery of the binding site, are important in steering these two proteins together (30, 31) .
The sequence homology between different IFN␣s is ϳ70% and 30% between IFN␣ and IFN␤. Comparison of functionally important residues on a sequence alignment of different type I IFNs shows that some of the residues interacting with ifnar2 are not fully conserved, including some of the hot-spot residues on the A-and E-helices (Fig. 7) ; Leu-15 is a Met in IFN␣5 and a Cys in IFN␤. Ala-145 is a Met in IFN and a Val in IFN␤. The dissociation constant K D of the A145M mutation (in IFN␣2) is 5-fold lower than A145G, yet 8-fold higher than Ala at this position (see Table I ). Met-148 is a Leu in IFN␤, Ser152 is a Tyr and Leu-153 is a Val. Interestingly, Leu-153 is not fully conserved between different IFN␣s either. Comparing the binding epitopes for IFN␣2 and IFN␤ on ifnar2 indicates that both proteins interact with a similar set of residues, but with a very different relative contribution of binding energies within the binding site (17, 32) . This observation can be rationalized from the partial conservation of active site residues on IFN␣2 and IFN␤. Two of the six hot-spot residues and six of the nine remaining residues that contribute to binding are not conserved between these two interferons. In contrast to IFN␤, all six hot-spot residues on IFN␣2, and eight of the nine remaining active-site residues were found to be conserved on 10 of the 11 IFN␣s aligned.
A structure-function analysis of the ifnar2 binding site on IFN␤ has identified the A-and E-helices as well as the AB-loop as constituting the ifnar2 binding site (33) . A quantitative comparison between the results presented here and those of Runkel et al. (33) is difficult. First, there are differences in the methods of measurements, second, whereas we analyzed single mutations, Runkel et al. (33) analyzed multiple mutations only. However, some qualitative differences between IFN␣2 and IFN␤ seem to emerge. Whereas in IFN␤ residues Lys-135 and Glu-136 (homologous to Lys-133 and Lys-134 in IFN␣2) increase receptor binding affinity, they decrease anti-proliferative activity by 10-fold. In IFN␣2, the mutation K134A had no effect on binding, whereas K133A reduced both ifnar2 binding affinity and biological activity to a similar degree. The antiviral and anti-proliferative activity of the multiple IFN␤ mutant V147A/R151A/Y154A/N157A (all located on the E-helix) is less than 10-fold smaller compared with wild-type activity. Conversely, summing up the contributions of individual mutations on homologous positions on IFN␣2 (Ala-145, Arg-149, and Ser-152) implies a reduction of about 300-fold in activity, suggesting that the E-helix might be more important for IFN␣2 activity than for IFN␤. Thus it appears that, although IFN␣2 and IFN␤ bind ifnar2 on the same structural motifs, the distribution of binding energies within the binding site is different. Analogously, it has been shown that the relative importance of residues on ifnar2 toward IFN␣2 and IFN␤ differs significantly (17, 32) .
IFN␣2 and IFN␥ share no obvious sequence or overall structural homology. However, helix A, the AB-loop, and the F-helix of IFN␥ (which constitute the receptor I binding site) overlay onto helix A, the AB-loop, and the E-helix of IFN␣2 with a root mean squared deviation of 2.3 Å for 59 residues (see Fig. 8 and Ref. 8) . Interestingly, residues that participate in the IFN␥ and IFN␣2 receptor interactions are located at the same positions on the two helices and on the AB-loop (Fig. 8 ). This may suggest that ifn␥R binds IFN␥ in a similar orientation as ifnar2 binds IFN␣2. Despite the good structural homology between the binding sites of these two IFNs, there is little sequence homology between the active site residues of these two proteins. Helix D of IFN␣2 does not overlay any IFN␥ helix using this structural alignment. The biological activity of interferon is exerted through binding ifnar1 and ifnar2, the association of which causes the activation of multiple signal transduction pathways. Having available a large set of IFN␣2 mutants with distinct affinities and rate constants of binding ifnar2, we were able to elucidate the role of IFN binding to ifnar2 for anti-viral and anti-proliferative activity in quantitative terms. Thus, the first event activating the signal transduction cascade was correlated with markers for the final steps of two important, different signal transduction pathways induced by IFNs. The linear correlation of both anti-viral and anti-proliferative activities with the relative binding affinity observed for all mutants analyzed suggests that IFN␣2 binding is a rate-limiting event in activating the biological response. This result clearly establishes that the binding affinity of IFN␣2 to its receptor does not surpass the requirements for cellular activity, as found for human growth hormone (34) and proposed for IFN␤ (33) . Further quantitative mechanistic interpretation of the affinity-activity relationship requires a closer look at parameters determining anti-proliferative and anti-viral activities; the assay for anti-proliferative activity is based on a continuous inhibition of cell growth and therefore may be considerably distorted by experimental variables such as cell growth rates, incubation times, or sample volumes. Interpretation of this data in absolute quantitative terms is therefore not appropriate. In contrast, anti-viral activity is an unbiased parameter, because cells are either protected or lysed by the virus attack. Therefore, further interpretations are based on this data. On a double logarithmic scale, FIG. 6 . Hydrophobic and electrostatic surface representation of IFN␣2 and ifnar2-EC. The largest continuos hydrophobic patch on the protein surfaces, as identified using the computer program QUILT (29) is colored green. Dark green, hydrophobic patch overlapping the binding site; light green, hydrophobic patch does not overlap the binding site; yellow, binding site does not overlap the hydrophobic patch. The binding site was determined through mutagenesis. The electrostatic potential was calculated using the computer program GRASP (36) , with the ionic strength set at 0.1 M. The contours are drawn at 0.7 kT/e (blue, positive potential; red, negative potential). The structure of IFN␣2 is from Ref. 8 , and the structure of ifnar2-EC is modeled according to its homology to ifna␥R (17, 37) . the linear correlation of IFN affinity with its anti-viral activity yielded a slope 0.72 Ϯ 0.02. Because the logarithm of the affinity is a measure for the free energy ⌬G 0 of binding, the relative anti-viral potency p AV can be described by the function,
where G ifnar2 0 is the free energy of the ifnar2⅐EC-IFN␣2 complex for the different mutants. The correlation coefficient k in this equation is 1.34 mol/kcal, with p AV, 0 being ϳ3 ϫ 10 Ϫ7 . What does this constant offset mean? Because IFN binds to both ifnar1 and ifnar2 on the cell surface, the binding affinity toward ifnar2 is enhanced by cooperative binding of ifnar1. Thus, typically a 10 -100-fold higher affinity constant is observed for IFN binding to the cell surface receptor than for ifnar2 alone (35) . The constant offset in Equation 1 most likely accounts for this constant energetic contribution of ifnar1 to form the ternary complex, and the value p AV is in good agreement with the relative contribution of ifnar1. This result impressively corroborates that anti-viral activity is directly related to the number of occupied cell surface receptors. We therefore looked into the dose-time relationships of the activation of the cellular response. Picomolar concentrations of IFN are sufficient to achieve sufficient activation for anti-viral protection. At a concentration of 4 pM wild-type IFN␣2 (ϳ50% inhibition in the FIG. 8 . Structural alignment of the A-helix, the AB-loop, and the F-helix of IFN␥ (the receptor I binding site) onto the A-helix, the AB-loop, and the E-helix of IFN␣2. The root mean squared deviation for the 40 overlaid residues is 2.9 Å. IFN␥ is colored yellow and green (green for residues interacting with receptor 1 as determined from the structure (37)), IFN␣2 is colored gray and red (red for residues interacting with ifnar2 as determined in this work).
FIG. 7.
Sequence alignment of several type I IFNs. In the upper row, the location of all residues of IFN␣2 that were mutated are marked as follows: residues that do not contribute to binding (Ϫ), residues that contribute 0.5-2.0 kcal/mol (one asterisk), and residues that contribute more than 2 kcal/mol (two asterisks).
anti-viral assay), ϳ8 receptors per cell will be occupied by IFN, assuming a K D of 400 pM for the ternary complex and a total of 500 receptors per cell typical for WISH-cells. Thus, the concentration required for inducing anti-viral activity corresponds to only very few occupied receptors per cell, and higher doses should linearly increase the number of activated receptors. However, occlusion of IFN␣2 after different incubation periods indicated that activation is necessary over at least 4 h and cannot be compensated by higher doses over longer time periods. This result is in good agreement with the observation that the half-life of phosphorylated STAT1 and STAT2 is short, and therefore continuous tyrosine kinase activity of Jak1 and Tyk2 is required for prolonged transcription (25) .
The quantitative high-resolution description of the functional epitope of IFN␣2 for binding, and the strict correlation of binding affinity with both anti-viral and anti-proliferative activity, are important steps forwards in understanding IFN recognition by its receptor on a molecular level. We showed that the E-helix constitutes the center of the ifnar2 binding site, in excellent analogy to several other homologous cytokines. Binding affinity seems to be driven by hydrophobic forces, whereas association is driven by electrostatic complementarity. Structural differences between complexes of ifnar2 with different IFNs are probably minor, only the distribution of binding energy on essentially the same set of residues is different. How this translates into differences in activity has to be studied by structural tools. Based on the linear relation between affinity and activity we were able to explain dose and time dependency within the signal transduction pathway.
